NCT01348347View on ClinicalTrials.gov

BI 6727 (Volasertib) Monotherapy Phase I Trial in Japanese Patients With Advanced Solid Tumours

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 25, 2011

Primary Completion Date

August 27, 2012

Study Completion Date

May 15, 2014

Conditions
Neoplasms
Interventions
DRUG

Volasertib, low dose, d1q3w

Patient to receive low dose of Volasertib IV

DRUG

Volasertib, middle dose, d1q3w

Patient to receive middle dose of Volasertib IV

DRUG

Volasertib, high dose, d1q3w

Patient to receive high dose of Volasertib IV

Trial Locations (1)

Unknown

1230.15.001 National Cancer Center Hospital,, Chuo-ku, Tokyo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY